KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organon (OGN) Current Assets (2020 - 2025)

Historic Current Assets for Organon (OGN) over the last 6 years, with Q3 2025 value amounting to $4.7 billion.

  • Organon's Current Assets fell 117.75% to $4.7 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $4.7 billion, marking a year-over-year decrease of 117.75%. This contributed to the annual value of $4.3 billion for FY2024, which is 354.92% down from last year.
  • Per Organon's latest filing, its Current Assets stood at $4.7 billion for Q3 2025, which was down 117.75% from $4.6 billion recorded in Q2 2025.
  • In the past 5 years, Organon's Current Assets ranged from a high of $4.8 billion in Q3 2024 and a low of $3.0 billion during Q1 2021
  • Over the past 5 years, Organon's median Current Assets value was $4.0 billion (recorded in 2023), while the average stood at $4.1 billion.
  • Within the past 5 years, the most significant YoY rise in Organon's Current Assets was 2492.44% (2022), while the steepest drop was 1702.47% (2022).
  • Organon's Current Assets (Quarter) stood at $3.8 billion in 2021, then increased by 4.55% to $3.9 billion in 2022, then rose by 14.68% to $4.5 billion in 2023, then decreased by 3.55% to $4.3 billion in 2024, then increased by 8.1% to $4.7 billion in 2025.
  • Its last three reported values are $4.7 billion in Q3 2025, $4.6 billion for Q2 2025, and $4.4 billion during Q1 2025.